Lipid Nanoparticles white paper updated thumbnail

Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles were propelled into the global spotlight for their role in two approved COVID mRNA vaccines. However, lipid nanoparticles aren't unique, in fact their development started decades ago as liposomes and as critical drug delivery vehicles. Only now, has more and more opportunities for advancement and applications emerged.

Lipid Nanoparticles white paper cover

{{lipid="/ads"}}

Download the CAS Insights Report

Related CAS Insights

Highlights from the CAS Insights webinar on the pharmaceutical patent landscape

White immune cells attacking a large pink cancer cell on a red tissue surface.

New translational research in immuno-oncology may reach patients who do not respond to current therapies

Pharmaceutical capsule containing a glowing orange DNA helix on a dark circuit board background.

CAS Insights Report: Unlocking the future of pharmaceutical innovation through patent intelligence.

Gain new perspectives for faster progress directly to your inbox.